BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies
BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.
Marc Sauer Lily Ramsey Chris Barbosa Acuitas Therapeutics Inc Technology Development Acuitas Therapeutics
Source: news-medical.net